MRNAModerna
$200.13+637% 1Y
$200.13
$22.3652 weeks$246.66
Is the price fair?
What MRNA's price assumes
Moderna did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 12.4× revenue.
12.4
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 4.10
Price / book · as of 2026-Q2
- EV / sales
- 10.4
EV / sales
Details›
- Price / bookas of 2026-Q2
- 4.10
- EV / EBIToperating margin −149%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 10.4
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry